Universal Token financial metrics
Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic.
Latest period: Q4 2025.
-
Symbol
-
UTKN on OTC
-
Location
-
San Salvador
-
Fiscal year end
-
31 December
-
Latest financial report
-
31 Mar 2026
Quick Takeaways
- UTKN - Universal Token financial facts are built from SEC company filings data.
- Latest metrics period on this page: Q4 2025.
- Headline metric: Return On Equity -74%.
What Changed
- Return On Equity YoY change: <span class="text-red-600">-133%</span>.
- Most recent SEC facts end date: 31 Dec 2025.
Why This Matters
- This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
- Every metric card links to a deeper SEC-backed history page for verification.
Official SEC Source
Based on latest 10-Q/10-K
Facts and ratios are grounded in SEC company facts linked to the latest 10-Q/10-K cycle.
See Original Filing
Latest SEC snapshot (2025-12-31) highlights Return On Equity -73.8%, Return On Assets -42.8%, and Current Ratio 0.43x.
Financial Quality Score
Transparent 0-100 scoring model based on profitability, financial health, and growth factors.
11.0/100
Weak
Confidence low
Return On Equity
-74%
Metric score 0.0/100
Return On Assets
-43%
Metric score 0.0/100
Financial Health
- Current Ratio
- 0.43x
Strengths
No strong signals yet.
Watchpoints
Return On Equity, Return On Assets, and NetIncomeLoss YoY
Key metrics snapshot
Return On Equity
-74%
YoY: -133%
Industry median:
-7.7%
(n=122)
View history
Return On Assets
-43%
YoY: -32%
Industry median:
-10%
(n=122)
View history
Current Ratio
0.43x
YoY: +241%
Industry median:
1.28x
(n=84)
View history
NetIncomeLoss YoY
-114%
YoY:
Industry median:
-104%
(n=105)
View history
Profitability
| Metric |
Latest value |
YoY change |
Industry median |
Calendar period |
Fiscal period |
Unit |
|
Return On Equity
|
-74%
|
-133%
|
-7.7%
(n=122)
|
Q4 2025
|
FY 2025
|
%
|
|
Return On Assets
|
-43%
|
-32%
|
-10%
(n=122)
|
Q4 2025
|
FY 2025
|
%
|
Financial Health
| Metric |
Latest value |
YoY change |
Industry median |
Calendar period |
Fiscal period |
Unit |
|
Current Ratio
|
0.43x
|
+241%
|
1.28x
(n=84)
|
Q4 2025
|
FY 2025
|
x
|
Growth
| Metric |
Latest value |
YoY change |
Industry median |
Calendar period |
Fiscal period |
Unit |
|
NetIncomeLoss YoY
|
-114%
|
|
-104%
(n=105)
|
Q4 2025
|
FY 2025
|
%
|
Share Metrics
| Metric |
Latest value |
YoY change |
Calendar period |
Fiscal period |
Unit |
|
Entity Common Stock, Shares Outstanding
|
101,561,000
|
+0.86%
|
Q4 2025
|
FY 2025
|
shares
|
|
Common Stock, Shares, Outstanding
|
101,561,000
|
+0.86%
|
Q4 2025
|
FY 2025
|
shares
|
|
Common Stock, Value, Issued
|
$101,561
|
+0.86%
|
Q4 2025
|
FY 2025
|
USD
|
|
Weighted Average Number of Shares Outstanding, Basic
|
101,358,304
|
+0.66%
|
Q4 2025
|
FY 2025
|
shares
|
|
Weighted Average Number of Shares Outstanding, Diluted
|
101,358,304
|
+0.66%
|
Q4 2025
|
FY 2025
|
shares
|
Additional Metrics
| Metric |
Latest value |
YoY change |
Calendar period |
Fiscal period |
Unit |
|
General and Administrative Expense
|
$51,762
|
+439%
|
Q4 2025
|
FY 2025
|
USD
|
|
Operating Income (Loss)
|
$355,026
|
-126%
|
Q4 2025
|
FY 2025
|
USD
|
|
Nonoperating Income (Expense)
|
$2,860
|
|
Q4 2025
|
FY 2025
|
USD
|
|
Earnings Per Share, Basic
|
0
|
|
Q4 2025
|
FY 2025
|
USD/shares
|
|
Earnings Per Share, Diluted
|
0
|
|
Q4 2025
|
FY 2025
|
USD/shares
|
|
Assets, Current
|
$12,930
|
-85%
|
Q4 2025
|
FY 2025
|
USD
|
|
Assets
|
$1,151,236
|
+124%
|
Q4 2025
|
FY 2025
|
USD
|
|
Liabilities, Current
|
$30,000
|
-96%
|
Q4 2025
|
FY 2025
|
USD
|
|
Liabilities
|
$30,000
|
-96%
|
Q4 2025
|
FY 2025
|
USD
|
|
Accumulated Other Comprehensive Income (Loss), Net of Tax
|
$0
|
-100%
|
Q4 2025
|
FY 2025
|
USD
|
|
Retained Earnings (Accumulated Deficit)
|
$535,219
|
-199%
|
Q4 2025
|
FY 2025
|
USD
|
|
Stockholders' Equity Attributable to Parent
|
$1,121,236
|
|
Q4 2025
|
FY 2025
|
USD
|
|
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
|
$1,121,229
|
|
Q4 2025
|
FY 2025
|
USD
|
|
Liabilities and Equity
|
$1,151,236
|
+124%
|
Q4 2025
|
FY 2025
|
USD
|
|
Common Stock, Shares Authorized
|
750,000,000
|
0%
|
Q4 2025
|
FY 2025
|
shares
|
|
Common Stock, Shares, Issued
|
101,561,000
|
+0.86%
|
Q4 2025
|
FY 2025
|
shares
|
|
Common Stock, Par or Stated Value Per Share
|
0.001
|
0%
|
Q4 2025
|
FY 2025
|
USD/shares
|
|
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
|
$1,842
|
-97%
|
Q4 2025
|
FY 2025
|
USD
|
|
Deferred Tax Assets, Valuation Allowance
|
$118,952
|
+164%
|
Q4 2025
|
FY 2025
|
USD
|
|
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
|
$355,946
|
-124%
|
Q4 2025
|
FY 2025
|
USD
|
|
Deferred Tax Assets, Operating Loss Carryforwards
|
$118,952
|
+164%
|
Q4 2025
|
FY 2025
|
USD
|
|
Additional Paid in Capital
|
$1,544,894
|
|
Q4 2025
|
FY 2025
|
USD
|
How we score
This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.
| Metric |
Weight |
V1 threshold |
| ROIC | 20 | 5% to 20% |
| ROE | 15 | 8% to 25% |
| ROA | 10 | 2% to 10% |
| Operating Margin | 5 | 5% to 25% |
| Current Ratio | 12 | 1.0x to 2.0x |
| Quick Ratio | 8 | 0.8x to 1.5x |
| Debt to Equity | 10 | 0.3x to 2.0x (lower is better) |
| Revenue YoY | 10 | -10% to +20% |
| Net Income YoY | 10 | -10% to +20% |
How Calculated (standard_v1)
Metrics are computed with a market-consensus convention designed for cross-portal comparability.
- TTM Operating Income / TTM Revenues
- Current Assets / Current Liabilities (latest instant quarter)
- (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
- Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
- TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
- TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
- TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
- TTM Revenues YoY
- TTM Net Income YoY
Explore related SEC datasets